Key takeaways Anxiety is not a common side effect of Wegovy, but some people may experience symptoms of anxiety due to the drugs other side effects, such as hypoglycemia or dehydration
McLaughlin breaks down who may qualify for GLP-1 therapy You may be a candidate if you have: BMI 30 (obesity), or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea) Type 2 diabetes or prediabetes Insulin resistance or metabolic syndrome Cardiovascular risk factors where weight loss would improve outcomes GLP-1s are typically not approved for patients with: Personal or family history of medullary thyroid cancer or MEN2 Prior severe pancreatitis linked to GLP-1 use Significant untreated GI disorders or eating disorders Approval may also depend on insurance requirements, documented lifestyle attempts, and whether the prescription is for diabetes vs
Lab data revealed hypernatremia (157 mEq/L), hyperkalemia (5.3 mEq/L), high LDH (1448 U/L), and CPK (2620 U/L), in favor of rhabdomyolysis
Whatever makes you feel good and look good
While tirzepatide has not been shown to directly cause gastrointestinal ulceration in clinical trials, its effects on motility and bowel habits may create conditions where bleeding from benign sources becomes more likely
